Current status: 1121 hESC lines, 7569 hiPSC lines, and 205 clinical studies, and 2402 certificates
Monthly statistic from Jan 1, 2026
Posted on January 1, 2026
| total lines | 8690 |
| hESC lines | 1121 |
| hiPSC lines | 7569 |
| derivation countries | 52 |
| projects | 333 |
| providers | 1028 |
| clinical studies | 205 |
| subclones | 3922 |
| certificates | 2402 |
| cell line certificates | 2247 |
| project certificates | 155 |